AntNano Singapore Pte Ltd

1

• AntNano Singapore Pte Ltd
• A specialist environmental and biomedical
• Nanotechnology company
• A Nanotech Ventures
• Case Study
• Dr Allan Syms
• November 2008

2
Nanotech Ventures

• An investment company
• Established to acquire equity in novel
  nanotechnology intellectual property (IP) with
  robust patent positions
• From leading universities in the USA, Europe
  and Asia.

3
Nanotech Ventures

• Strategy to support nanotechnology companies that
  meet NTVs investment criteria
• With funds to enable translation of the IP to
  stage where it can be transferred to a commercial
  organisation through licensing.
• NTV may elect to exit via an IPO or trade sale,
  thus generating added value for shareholders.

4
Nanotech Ventures

• Huge market potential for nanomaterial-based
  products
• Environment, energy, medial, construction,
  textile, automotive, household and personal care.
  
• Estimated market place for nanotechnology
  products and services US1 trillion by 2015
  (Source National Science Foundation).

5
Nanotech Ventures

• Company led by experienced management team
• Blend of scientific, commercial and investment
  skills.
• Team has developed quoted companies in bio and
  nanotechnology worth 400m.

6

• Mr Joe Arend Chairman
• Founder of AntNano and ex senior director of
  Proctor and Gamble, Rhone Poulenc. Founding
  member of successful start-ups
• Dr Allan Syms Chief Executive
• Ex CEO of nanotechnology and sensor start-ups
  resulting in public listing
• Prof Fred Rowell Chief Scientific Officer
• Founder of AntNano and renowned expert in
  nanotechnology and enzyme measurement
• Harry Heng Director
• Entrepreneur, Director, Founder of consultancy
  and corporate finance firm

STRICTLY CONFIDENTIAL
7
AntNano Nanotechnology

• Hydrophobic nanoparticles and ultra sensitive
  microelectrodes
• Designed and validated system for monitoring
  airborne analytes

Global rights to use and develop patented
microelectrode technology
STRICTLY CONFIDENTIAL
8

Current Product Range

High Volume Air Sampling
Real Time Measurement
Monitoring of Airborne Enzymes
Analytical Services
Dip Strip Screening
9
Business Model

• Revenue from state-of-the-art air analysis
  instrumentation
• Recurring revenue from disposable test systems
  (bioreactors/dip strips) and disposable
  microsensors
• Three focussed business units

Counter Terrorism Detection of explosive devices
Biomedical Infectious Disease Avian Flu MRSA
Industrial Dioxins Enzymes Oestrogenic Steroids
10
 

Route to Market

• Group is a world leader in static airborne
  industrial enzyme monitoring (via Newton)
• 600 installations worldwide that presents
  immediate access for real-time analysers,
  bioreactors, and dip strips
• Currently established in the detergent industry
  horizontal marketing segments such as food and
  beverage, tannery, paper and pulp, animal feed
• Corporate partnerships and licensing by
  combining new sensor technologies with existing
  air monitoring nanotechnologies

STRICTLY CONFIDENTIAL
11
 

Customers

• Initially concentrating sales and marketing
  (Consortium members)
• Unilever Limited
• The Procter Gamble Company
• Johnson Diversey Limited
• Novozymes A/S

STRICTLY CONFIDENTIAL
12

Unique Sustainable Advantages

• Company core competences and advantages
• Core team of experienced managers, research
  scientists and engineers in the application of
  nanotechnologies is a variety of markets
• Strong suite of patents and expected
  commercialisable new discoveries and novel
  inventions
• Providing real time analysis of airborne chemical
  and biological agents

• Products capabilities and advantages
• Inexpensive (a few S versus gtS150/lab-based
  analysis)
• Rapid (a fee minutes versus gt a few days for
  lab-based analysis)
• Specific
• Sensitive
• Suitable for non-invasive testing
• Easy to use

STRICTLY CONFIDENTIAL
13

Conclusion

STRICTLY CONFIDENTIAL